Guidelines suggesting drugs, surgery for child obesity get backlash

Comment on this story Comment Within hours of the release of new treatment guidelines for childhood obesity last week, Mary Savoye’s inbox began to fill up with haranguing emails. The…

FDA Approves QSYMIA® for the Treatment of Obesity in Adolescents Ages 12-17

VIVUS, Inc. CAMPBELL, Calif., July 20, 2022 (World NEWSWIRE) — VIVUS LLC currently introduced that the U.S. Food items and Drug Administration (Food and drug administration) authorised QSYMIA (phentermine and…